3 Footsie giants you should consider buying before it’s too late

Royston Wild looks at three FTSE 100 (INDEXFTSE: UKX) stunners you shouldn’t wait to buy.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The FTSE 100’s gaggle of homebuilders have continued to defy predictions of a slump in the housing market following last summer’s Brexit vote. Despite this fact, the sector continues to trade at a discount to its pre-referendum levels, and Barratt Developments (LSE: BDEV) for one is dealing 13% cheaper that it did on June 23.

I reckon investors continue to underestimate the builder’s strong earnings outlook at current prices, and expect the company’s next trading update (scheduled for Wednesday, February 22) to prompt a fresh share price spurt.

Sector rivals Persimmon and Taylor Wimpey have both been busy releasing chirpy market updates in recent sessions. And this comes as no surprise as favourable lending conditions continue to propel demand — indeed, the Bank of England advised this month that mortgage approvals hit an eight-month high of 67,505 in November

Should you invest £1,000 in Bakkavor right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Bakkavor made the list?

See the 6 stocks

And Barratt Developments’ ultra-low valuations certainly leave room for a renewed move higher. For the period to June 2017 the firm deals on a P/E ratio of just 9.4 times, while the company also carries a market-mashing dividend yield of 6.9%.

Plane brilliance

The outlook for easyJet (LSE: EZJ) is a little more complicated, in my opinion, as the Brexit issue crimps consumer confidence and heaps inflationary pressures on holiday budgets. Meanwhile, the orange-and-white flyer also faces pressure from rising fuel costs and the impact of terrorist-related incidents in key destinations.

Having said that, I reckon there’s still plenty for investors to be optimistic about. Demand for easyJet’s cut-price seats continues to head through the roof — passenger numbers shot 15.1% higher in December, to 5.6m — and these are likely to keep rising as travellers demand more bang for their buck.

Furthermore, while easyJet has dialled back its expansion plans a touch recently, the company remains optimistic that its route expansion across the continent should deliver meaty revenues growth in the long term.

And I reckon the risks facing it are baked-in at current share prices. For the year to September 2017, the airline deals on a P/E ratio of 12.5 times, comfortably below the big-cap forward average of 15 times. Meanwhile, a dividend yield of 4.1% also outstrips the broader market.

The right medicine

Despite the City expecting earnings to flip higher again at GlaxoSmithKline (LSE: GSK), the market remains lukewarm over the medicines mammoth’s growth outlook. And this is reflected in the company’s pretty low valuations.

For 2017 the firm deals on a P/E rating of 14.1 times. And the business is exceptionally cheap in the dividend department — a yield of 5.1% smashes the prospective average of 3.5% for the FTSE 100.

But I reckon investors may be missing out here. GlaxoSmithKline is concentrating on rapidly-growing therapy segments like HIV, COPD and vaccines to deliver future sales growth, and the success of recently-launched products such as Bexsero and Tivicay helped total new product sales roll 79% higher during July-September, to £1.21bn.

And GlaxoSmithKline’s packed development pipeline leaves the firm in great shape to deliver the next generation of revenues drivers. I believe it could see its share price shoot higher should, as I expect, the business furnish the market with a slew of new drugs in the years ahead.

But this isn’t the only opportunity that’s caught my attention this week. Here are:

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report5 Shares for the Future of Energy — and discover:

  • Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
  • How to potentially get paid by the weather
  • Electric Vehicles’ secret backdoor opportunity
  • One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Road 2025 to 2032 new year direction concept
Investing Articles

Up 909% in 3 years! Can Rolls-Royce shares carry on climbing?

Nothing good lasts forever, although Rolls-Royce shares are giving it their best shot. Harvey Jones wonders when they will finally…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

3 techniques to turbocharge your SIPP for a richer retirement!

Christopher Ruane considers a trio of ways he thinks an investor could use to try and grow the long-term value…

Read more »

ISA coins
Investing Articles

With a £20,000 Stocks and Shares ISA, here’s how someone could make £762 each month in passive income

A well-invested Stocks and Shares ISA might rise in value due to share price growth -- but it can also…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

Just released: our 3 top small-cap stocks to consider buying in June [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

I asked ChatGPT which stocks will be promoted to the FTSE 100. Here’s what it said!

Each quarter, stocks are promoted to or relegated from the FTSE 100 index. ChatGPT reckons these UK shares are ones…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

How many Legal & General shares must an investor buy to earn £1k of monthly passive income?

Harvey Jones calculates how much passive income someone could earn by taking a big position in one of the FTSE…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

If I couldn’t touch my ISA or SIPP for 10 years, I’d be happy owning these super stocks

Edward Sheldon has been analysing his ISA and pension stock holdings. And he believes these two companies will still be…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

7% yields and low P/E ratios? These 2 cheap shares look promising!

The FTSE All-share is a great place to hunt for cheap shares, in my opinion. I've uncovered two top dividend…

Read more »